University of Hawaii Cancer Center Researcher Awarded $1.8M to Predict Risk of Chemotherapy Side Effects
December 07, 2021
December 07, 2021
HONOLULU, Hawaii, Dec. 7 (TNSOps) -- The University of Hawaii Cancer Center issued the following news:
The National Cancer Institute has awarded University of Hawaii Cancer Center's Alexandra Binder, ScD, $1.8 million to investigate how epigenetic age can be used to characterize the risk of chemotherapy side effects, and whether an exercise intervention can reduce the rate of epigenetic aging over treatment. Binder and collaborators hope to use findings from this study to impro . . .
The National Cancer Institute has awarded University of Hawaii Cancer Center's Alexandra Binder, ScD, $1.8 million to investigate how epigenetic age can be used to characterize the risk of chemotherapy side effects, and whether an exercise intervention can reduce the rate of epigenetic aging over treatment. Binder and collaborators hope to use findings from this study to impro . . .